An Interview With Dr. Vallerie McLoughlin, Director of the University of Michigan's Pulmonary Hypertension Program
From Rare Care Podcast by Rare Disease Advisor
May 26, 2026 · 9 min · Season 1 · Episode 226
About this episode
Larry Luxner interviews Dr. Vallerie McLoughlin about a phase 3 trial for ralinepag to treat pulmonary arterial hypertension.
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Vallerie McLoughlin, MD, director of the Pulmonary Hypertension Program at the University of Michigan-Ann Arbor, about results of a phase 3 trial for ralinepag to treat pulmonary arterial hypertension.
People in this episode
Host: Larry Luxner
Guest: Vallerie McLoughlin
Topics covered
- pulmonary hypertension
- clinical trials
- interview
- healthcare
- rare diseases
Keywords
- pulmonary hypertension
- ralinepag
- clinical trial
- Vallerie McLoughlin
- rare diseases
Mentioned in this episode
Organizations: University of Michigan, Pulmonary Hypertension Program
Products: ralinepag
Places: Michigan, Ann Arbor
More episodes of Rare Care Podcast
- An Interview With Dr. Michelle Ng Gong, New President of the American Thoracic Society · June 9, 2026 · 11 min
- An Interview With Dr. Andrew Wilson, Scientific Director of the Alpha-1 Foundation · May 31, 2026 · 8 min
- An Interview With Craig Martin, Founder and CEO of the Orphan Therapeutics Accelerator · May 18, 2026 · 15 min
- An Interview With Henriette Farkas, Director of the Hungarian Angioedema Reference Center in Budapest · May 14, 2026 · 13 min
- An Interview With Dr. Antón Blatnik on the Molecular Mechanisms Driving Neuromuscular Disease · May 4, 2026 · 11 min
- An Interview With SMA Expert and Neurologist Dr. Kathryn Swoboda · April 27, 2026 · 15 min
Explore listener stats, chart rankings, contacts and more on the Rare Care Podcast podcast page.